“…The corresponding eigenfunction ψ is simple and can be chosen such that ψ(x) > 0 for all x ∈ Ω and normalised such that ψ ∞ = 1. The proofs in [17] using the direct method in the calculus of variations are easily adapted to our situation (see [6,Section 2] or [16,Theorem 3.4]). Note that the very elegant and simple proof from [13,2] could be adapted.…”
Section: A Level Set Representation For the First Eigenvaluementioning
Abstract. We give a simple proof of the Faber-Krahn inequality for the first eigenvalue of the p-Laplace operator with Robin boundary conditions. The techniques introduced allow to work with much less regular domains by using test function arguments. We substantially simplify earlier proofs, and prove the sharpness of the inequality for a larger class of domains at the same time.
“…The corresponding eigenfunction ψ is simple and can be chosen such that ψ(x) > 0 for all x ∈ Ω and normalised such that ψ ∞ = 1. The proofs in [17] using the direct method in the calculus of variations are easily adapted to our situation (see [6,Section 2] or [16,Theorem 3.4]). Note that the very elegant and simple proof from [13,2] could be adapted.…”
Section: A Level Set Representation For the First Eigenvaluementioning
Abstract. We give a simple proof of the Faber-Krahn inequality for the first eigenvalue of the p-Laplace operator with Robin boundary conditions. The techniques introduced allow to work with much less regular domains by using test function arguments. We substantially simplify earlier proofs, and prove the sharpness of the inequality for a larger class of domains at the same time.
“…We can view problem (P λ ) as a perturbation of the classical eigenvalue problem for the Robin p-Laplacian, investigated by Lê [12] and Papageorgiou and Rădulescu [15]. Similar studies concerning positive solutions, were conducted by Brezis and Oswald [5] (for problems driven by the Dirichlet Laplacian) and by Diaz and Saa [6] (for problems driven by the Dirichlet p-Laplacian).…”
Section: Also ∂U ∂Npmentioning
confidence: 92%
“…This eigenvalue problem was studied by Lê [12] and Papageorgiou and Rădulescu [15]. We say that λ ∈ R is an eigenvalue of the negative Robin p-Laplacian (denoted by −∆ R p ), if problem (E λ ) admits a nontrivial solution u, known as an eigenfunction corresponding to the eigenvalue λ.…”
Section: Also ∂U ∂Npmentioning
confidence: 99%
“…All the other eigenvalues have nodal (sign-changing) eigenfunctions. For more about the higher parts of the spectrum of −∆ R p , we refer to Lê [12] and Papageorgiou and Rădulescu [15].…”
Abstract. We study perturbations of the eigenvalue problem for the Robin p-Laplacian. First we consider the case of a (p − 1)-sublinear perturbation and prove existence, nonexistence and uniqueness of positive solutions. Then we deal with the case of a (p − 1)-superlinear perturbation which need not satisfy the Ambrosetti-Rabinowitz condition and prove a multiplicity result for positive solutions. Our approach uses variational methods together with suitable truncation and perturbation techniques.
“…[1,6,15,13,7,8,3,10,5,11,2,12,16,4,9] and the references therein). In particular, we present here some results that motivated this work: First, we mention the result in [8], that we consider as a principal key for the development of our results.…”
This work deals with an indefinite weight one dimensional eigenvalue problem of the p-Laplacian operator subject to Neumann boundary conditions. We are interested in some properties of the spectrum like simplicity, monotonicity and strict monotonicity with respect to the weight. We also aim the study of zeros points of eigenfunctions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.